[go: up one dir, main page]

BG103997A - Средство за трансдермално въвеждане терапевтичен агент и методи за лечение на вирусни и бактериалниинфекции и синдрома на изтощението - Google Patents

Средство за трансдермално въвеждане терапевтичен агент и методи за лечение на вирусни и бактериалниинфекции и синдрома на изтощението

Info

Publication number
BG103997A
BG103997A BG103997A BG10399799A BG103997A BG 103997 A BG103997 A BG 103997A BG 103997 A BG103997 A BG 103997A BG 10399799 A BG10399799 A BG 10399799A BG 103997 A BG103997 A BG 103997A
Authority
BG
Bulgaria
Prior art keywords
viral
treatment
methods
east
syndrome
Prior art date
Application number
BG103997A
Other languages
Bulgarian (bg)
English (en)
Inventor
Michelle Olga VISSER
Original Assignee
Virodene Pharmaceutical Holdings/Proprietary/Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Virodene Pharmaceutical Holdings/Proprietary/Limited filed Critical Virodene Pharmaceutical Holdings/Proprietary/Limited
Publication of BG103997A publication Critical patent/BG103997A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BG103997A 1997-06-13 1999-12-13 Средство за трансдермално въвеждане терапевтичен агент и методи за лечение на вирусни и бактериалниинфекции и синдрома на изтощението BG103997A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en) 1997-06-13 1998-06-09 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (1)

Publication Number Publication Date
BG103997A true BG103997A (bg) 2001-07-31

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103997A BG103997A (bg) 1997-06-13 1999-12-13 Средство за трансдермално въвеждане терапевтичен агент и методи за лечение на вирусни и бактериалниинфекции и синдрома на изтощението

Country Status (34)

Country Link
EP (1) EP1011567A4 (xx)
JP (1) JP4531141B2 (xx)
KR (1) KR20010013709A (xx)
CN (1) CN1260703A (xx)
AP (1) AP1629A (xx)
AR (1) AR012970A1 (xx)
AU (1) AU7831598A (xx)
BG (1) BG103997A (xx)
BR (1) BR9810095A (xx)
CA (1) CA2295176A1 (xx)
CZ (1) CZ298510B6 (xx)
EA (1) EA200000011A1 (xx)
EE (1) EE9900562A (xx)
ES (1) ES2161187B1 (xx)
FI (1) FI19992648L (xx)
GB (1) GB2341319B (xx)
HU (1) HUP0003034A2 (xx)
ID (1) ID23516A (xx)
IL (2) IL133396A0 (xx)
IS (1) IS5289A (xx)
LT (1) LT4714B (xx)
LV (1) LV12490B (xx)
NO (1) NO996117L (xx)
NZ (1) NZ501669A (xx)
OA (1) OA11307A (xx)
PL (1) PL196256B1 (xx)
RO (1) RO121252B1 (xx)
SI (1) SI20191A (xx)
SK (1) SK172299A3 (xx)
TN (1) TNSN98086A1 (xx)
TR (1) TR200000540T2 (xx)
WO (1) WO1998056325A1 (xx)
YU (1) YU66099A (xx)
ZA (1) ZA984649B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1638468T3 (pl) * 2003-06-30 2008-01-31 Alza Corp Sposób powlekania mikrowystępów do przekłuwania skóry
OA13331A (en) * 2003-12-05 2007-04-13 Namibia Medical Invest Pty Ltd Patch.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
JP3309104B2 (ja) * 1992-02-20 2002-07-29 メレルダウファーマス−ティカルズ インコーポレイテッド ウイルス病治療用のスルホン酸誘導体類
SI9620126A (sl) * 1995-12-15 1999-10-31 Cryopreservation Technologies Cc (Za/Za) Spojina za kriogensko ohranjanje organov in zdravljenje virusnih ter bakterijskih infekcij

Also Published As

Publication number Publication date
LV12490B (en) 2000-12-20
GB2341319A (en) 2000-03-15
PL338439A1 (en) 2000-11-06
SI20191A (sl) 2000-10-31
GB9929189D0 (en) 2000-02-02
ID23516A (id) 2000-04-27
AU7831598A (en) 1998-12-30
WO1998056325A1 (en) 1998-12-17
LT99148A (lt) 2000-07-25
PL196256B1 (pl) 2007-12-31
TNSN98086A1 (fr) 2005-03-15
FI19992648A7 (fi) 2000-02-03
CA2295176A1 (en) 1998-12-17
EP1011567A1 (en) 2000-06-28
LV12490A (en) 2000-06-20
EP1011567A4 (en) 2000-06-28
KR20010013709A (ko) 2001-02-26
TR200000540T2 (tr) 2000-09-21
YU66099A (sh) 2002-10-18
JP2002511862A (ja) 2002-04-16
NO996117L (no) 2000-02-11
OA11307A (en) 2003-10-24
RO121252B1 (ro) 2007-02-28
CZ298510B6 (cs) 2007-10-24
JP4531141B2 (ja) 2010-08-25
EE9900562A (et) 2000-06-15
AP9901708A0 (en) 1999-12-31
CN1260703A (zh) 2000-07-19
EA200000011A1 (ru) 2000-08-28
NZ501669A (en) 2001-09-28
AP1629A (en) 2006-07-11
SK172299A3 (en) 2000-09-12
FI19992648L (fi) 2000-02-03
ZA984649B (en) 1999-12-17
IL133396A (en) 2006-10-05
NO996117D0 (no) 1999-12-10
LT4714B (lt) 2000-10-25
IS5289A (is) 1999-12-08
AR012970A1 (es) 2000-11-22
HUP0003034A2 (hu) 2000-12-28
ES2161187A1 (es) 2001-11-16
BR9810095A (pt) 2001-11-13
ES2161187B1 (es) 2003-08-16
GB2341319B (en) 2002-02-27
IL133396A0 (en) 2001-04-30
CZ9904473A3 (cs) 2001-03-14

Similar Documents

Publication Publication Date Title
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
ATE309271T1 (de) Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen
ATE295176T1 (de) Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen
UA73115C2 (en) Use of dipeptidyl peptidase iv inhibitors for treating short stature due to growth hormone deficiency
DE69030880D1 (de) Zusammensetzung zur Stimulierung des Immunsystems
DE69734215D1 (de) Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
ATE366312T1 (de) Impfstoff und antitoxine zur behandlung und vorbeugung von c. difficile krankheiten
DE69718612D1 (de) Verfahren zur konservierung von infektiösen rekombinierenden viren, virale wässrige suspension und ihre medizinische verwendung
ATE399562T1 (de) Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen
DE69631381D1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
BG103997A (bg) Средство за трансдермално въвеждане терапевтичен агент и методи за лечение на вирусни и бактериалниинфекции и синдрома на изтощението
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
Eldad, A., Stark, M., Anais, D., Golan, J. & Ben-Hur Amniotic membranes as a biological dressing
Rosenberg et al. Antibiotic TA: an adherent antibiotic
SE9700244D0 (sv) Novel antibacterial protein
DK0950416T3 (da) Anvendelse af TCF-II til behandling af cancerrelateret tab af kropsvægt, anæmi og TNF-forhöjelse
RU2179846C2 (ru) Средство для профилактики и лечения желудочно-кишечных и респираторных заболеваний телят
SU1629062A1 (ru) Способ лечени колибактериоза тел т
RU2709841C1 (ru) Способ стимуляции репаративных процессов у животных после остеосинтеза
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
FR2792639B1 (fr) Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
DK1150981T3 (da) Terapeutisk necleosidforbindelse
FI972121A0 (fi) Sammansaettningar foer reciprok oekning av immunosupperssanters och interferoners farmaceutiska aktiviteter
ATE401349T1 (de) Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen